Back to search results
NCT03404778

Comprehensive Reverse Shoulder Data Collection

Enrolling by Invitation
Not specifiedAges 18+Observational
Zimmer Biomet
~175 participants
Updated 2025-10-30 on ClinicalTrials.gov
What's tested:Biomet Comprehensive Reverse Shoulder

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Pain Score
Measured over 1 year

Conditions

Arthropathy of Shoulder Region
Grossly Deficient Rotator Cuff
Osteoarthritis of the Shoulder
Rheumatoid Arthritis Without Humeral Metaphyseal Defects
Post-Traumatic Arthitis

Explore related trials

Grossly Deficient Rotator CuffOsteoarthritis of glenohumeral jointRevision of shoulder arthroplastyRheumatoid ArthritisTraumatic Arthritis

NCT03404778

Where you'd take part

This study runs at 4 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Acromion LLC

    Towson, Marylandno site contact published

  • Allina Health System DBA Sports and Orthopaedic Specialists

    Edina, Minnesotano site contact published

  • Joint Implant Surgeons

    New Albany, Ohiono site contact published

  • William Beaumont Hospital

    Royal Oak, Michiganno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Biomet® Comprehensive™ Reverse Shoulder products are indicated for use in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff.
The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary.
The Comprehensive® Reverse Shoulder is indicated for primary, fracture, or revision total shoulder replacement for the relief of pain and significant disability due to gross rotator cuff deficiency.

Exclusion

Absolute contraindications include infection, sepsis, and osteomyelitis.
Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions.
Osteoporosis.
Metabolic disorders which may impair bone formation.
Osteomalacia.
Distant foci of infections which may spread to the implant site.
Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram.

What this trial measures

  • Pain Score1 year

    Pain Score is assessed for each subject by asking them to indicate their current level of pain based on a 5 level scale, with "None" as the best outcome and "Severe" as the worst. Improvement of pain score at one year from pre-operative levels will be assessed.